digitoxin dig (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
digitoxin dig
Digitoxin Dig, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dig/Digitoxin/pmc13114880-39-2-7
Average 94 stars, based on 12 article reviews
Digitoxin Dig, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 12 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dig/Digitoxin/pmc13114880-39-2-7
Average 94 stars, based on 12 article reviews
digitoxin dig - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
other:Article Title: Unfolded protein response kinase PERK supports survival and metastasis of circulating tumor cell clusters via SAM synthesis and H3K4me3‐dependent PDGFB signaling Article Snippet: One week later, mice were randomly assigned to vehicle, digitoxin (0.5 mg/kg, HY‐B1357, MedChemExpress, Monmouth Junction, NJ, USA), or ouabain (0.86 mg/kg, HY‐B0542, MedChemExpress) groups, receiving treatment every other day from week 1 to week 4. Article Title: Unravelling the Interaction Mechanism Between Oryzanol and Human Serum Albumin: An Integrated Approach Using Multispectral Analysis and Molecular Simulations Article Snippet: Ory and Article Title: Exploring the anticancer mechanism of cardiac glycosides using proteome integral solubility alteration approach Article Snippet: Digoxin (HY‐B1049), Digitoxin (HY‐B1357), Article Title: Unfolded protein response kinase PERK supports survival and metastasis of circulating tumor cell clusters via SAM synthesis and H3K4me3-dependent PDGFB signaling. Article Snippet: One week later, Article Title: Molecular interaction of abemaciclib with human serum albumin: Insights from spectroscopy, microscopy, and computational approaches. Article Snippet: Understanding drug–protein interactions at the biointerface is essential for predicting pharmacokinetics and guiding drug delivery strategies.. Here, we systematically investigated the binding mechanism of abemaciclib, a selective CDK4/6 inhibitor, with human serum albumin (HSA) using a combination of multi-spectroscopic techniques, atomic force microscopy (AFM), molecular docking, molecular dynamics (MD) simulation, and site-directed mutagenesis.. Fluorescence quenching and UV–Vis analyses revealed that abemaciclib interacts with HSA via a static mechanism, forming a 1:1 stoichiometric complex with moderate affinity (KA ~ 105 M 1). |